Cross-sectional study of blood biomarkers of patients with moderate to severe alopecia areata reveals systemic immune and cardiovascular biomarker dysregulation

86Citations
Citations of this article
65Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background: Although there is increased understanding of the alopecia areata (AA) pathogenesis based on studies in scalp tissues, little is known about its systemic profile. Objective: To evaluate the blood proteomic signature of AA and determine biomarkers associated with increased disease severity. Methods: In a cross-sectional study, we assessed 350 inflammatory and cardiovascular proteins using OLINK high-throughput proteomics in patients with moderate to severe AA (n = 35), as compared with healthy individuals (n = 36), patients with moderate to severe psoriasis (n = 19), and those with atopic dermatitis (n = 49). Results: Seventy-four proteins were significantly differentially expressed between AA and control individuals (false discovery rate,

Cite

CITATION STYLE

APA

Glickman, J. W., Dubin, C., Renert-Yuval, Y., Dahabreh, D., Kimmel, G. W., Auyeung, K., … Guttman-Yassky, E. (2021). Cross-sectional study of blood biomarkers of patients with moderate to severe alopecia areata reveals systemic immune and cardiovascular biomarker dysregulation. Journal of the American Academy of Dermatology, 84(2), 370–380. https://doi.org/10.1016/j.jaad.2020.04.138

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free